R

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Associate Director - Computational Chemistry

Biology & BiotechConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA

About the Job

Requirements

  • A Ph.D. in computational chemistry or a related field and 10 or more years of experience post-Ph.D.
  • Substantial computational chemistry experience in the biotechnology or pharmaceutical industry, with demonstrated scientific leadership across discovery programs and a record of influencing program strategy, advancing compounds, or enabling key discovery decisions.
  • Expert knowledge of computational chemistry methods for protein-ligand analysis and molecular design, including docking, virtual screening, pharmacophore modeling, molecular dynamics, and free energy or quantum mechanical calculations.
  • Experience developing, validating, and applying artificial intelligence/machine learning or data science approaches to drug discovery, with sound judgment in model evaluation, uncertainty, applicability, and experimental validation.
  • Strong scientific programming skills in Python or related languages, and experience with computational chemistry, cheminformatics, and machine learning software.
  • Ability to set scientific priorities, develop work plans, coordinate resources, and lead scientists or cross-functional programs; ability to influence senior stakeholders and communicate complex findings and recommendations clearly.
  • A collaborative leadership style, a record of mentoring scientists, and the ability to balance exploratory research with discovery timelines and deliverables.

Responsibilities

  • Serve as a computational chemistry lead on multidisciplinary discovery teams, shaping project direction and compound design from hit finding through lead optimization; integrate SAR, structural, biophysical, biochemical, and ADME/PK data to guide prioritization of Ro5 and bRo5 molecules.
  • Lead CompChem’s contribution to TQ by translating discovery strategy into computational objectives, work plans, and milestones; coordinate execution across TQ efforts and be accountable for quality, timeliness, and scientific impact.
  • Partner with medicinal chemistry, structural biology, biology, and screening leaders to define scientific questions, resolve discovery challenges, recommend priorities, and communicate evidence, uncertainties, and trade-offs to project teams and senior leadership.
  • Establish hit-finding strategies for novel protein and protein-protein interaction targets, including structure-based and ligand-based virtual screening and design of diverse chemical libraries.
  • Guide evaluation, development, and application of computational methods, including molecular dynamics, enhanced sampling, and free energy calculations, while remaining hands-on in modeling and molecular design problems.
  • Collaborate with Advanced Analytics to develop, validate, and apply AI/ML methods for computational chemistry and drug discovery.
  • Set computational priorities across assigned discovery programs and TQ responsibilities; identify staffing, compute, software, and external collaboration needs; provide budget and resource recommendations and track delivery against agreed plans.
  • Provide scientific leadership and lead cross-functional initiatives; establish standards for reproducibility, model evaluation, and knowledge sharing, and support adoption of effective methods across discovery teams.
  • Have the opportunity to manage and develop junior scientists, supporting their scientific development and contributions to discovery projects.

Desired Qualifications

  • Experience with Ro5 and bRo5 modalities, including macrocycles, molecular glues, tri-complex inhibitors, covalent ligands, or other challenging therapeutic modalities.
  • Experience working in high-performance computing (HPC) or cloud environments and developing scalable computational workflows.
  • A record of scientific innovation reflected in patents, publications, presentations, or adoption of methods that improve discovery outcomes.
  • Experience managing direct reports, external scientific collaborations, or budgets.

About the Company

Revolution Medicines

Clinical-stage oncology company developing RAS inhibitors

Revolution Medicines develops precision oncology drugs focused on cancers driven by RAS mutations. Its RAS(ON) inhibitors are small molecules that bind the active form of RAS to block cancer signaling, with candidates like Daraxonrasib (RMC-6236), Elironrasib (RMC-6291), and Zoldonrasib (RMC-9805) advancing in global Phase 3 trials. The company funds its research through collaborations, royalties, and upfront funding, and has not yet marketed a product. Its goal is to bring effective RAS-targeted therapies to patients and advance multiple candidates through late-stage trials toward approval, supported by strong cash reserves.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Redwood City, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Revolution Medicines

See more jobs